Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study

Krittika Teerapuncharoen; J. Michael Wells; S. Vamsee Raju; Karen S. Raraigh; Melis Atalar Aksit; Garry R. Cutting; Lawrence Rasmussen; P. Hrudaya Nath; Surya P. Bhatt; George M. Solomon; Mark T. Dransfield; Steven M. Rowe

doi:10.1513/AnnalsATS.201805-325RL

Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study

Krittika Teerapuncharoen, J. Michael Wells, S. Vamsee Raju, Karen S. Raraigh, Melis Atalar Aksit, Garry R. Cutting, Lawrence Rasmussen, P. Hrudaya Nath, Surya P. Bhatt, George M. Solomon, Mark T. Dransfield, Steven M. Rowe

School of Medicine

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	150-153
Number of pages	4
Journal	Annals of the American Thoracic Society
Volume	16
Issue number	1
DOIs	https://doi.org/10.1513/AnnalsATS.201805-325RL
State	Published - Jan 2019

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1513/AnnalsATS.201805-325RL

Cite this

Teerapuncharoen, K., Michael Wells, J., Vamsee Raju, S., Raraigh, K. S., Aksit, M. A., Cutting, G. R., Rasmussen, L., Hrudaya Nath, P., Bhatt, S. P., Solomon, G. M., Dransfield, M. T., & Rowe, S. M. (2019). Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study. Annals of the American Thoracic Society, 16(1), 150-153. https://doi.org/10.1513/AnnalsATS.201805-325RL

Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study. / Teerapuncharoen, Krittika; Michael Wells, J.; Vamsee Raju, S. et al.
In: Annals of the American Thoracic Society, Vol. 16, No. 1, 01.2019, p. 150-153.

Research output: Contribution to journal › Letter › peer-review

Teerapuncharoen, K, Michael Wells, J, Vamsee Raju, S, Raraigh, KS, Aksit, MA, Cutting, GR, Rasmussen, L, Hrudaya Nath, P, Bhatt, SP, Solomon, GM, Dransfield, MT & Rowe, SM 2019, 'Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study', Annals of the American Thoracic Society, vol. 16, no. 1, pp. 150-153. https://doi.org/10.1513/AnnalsATS.201805-325RL

@article{8a608db98f02406f9a66b44ba9b5067b,

title = "Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study",

author = "Krittika Teerapuncharoen and {Michael Wells}, J. and {Vamsee Raju}, S. and Raraigh, {Karen S.} and Aksit, {Melis Atalar} and Cutting, {Garry R.} and Lawrence Rasmussen and {Hrudaya Nath}, P. and Bhatt, {Surya P.} and Solomon, {George M.} and Dransfield, {Mark T.} and Rowe, {Steven M.}",

note = "Funding Information: Supported by National Institutes of Health grants K08 HL123940 (J.M.W.), R01 HL105487 (S.M.R.), P30 DK072482 (S.M.R.), R01 DK44003 (G.R.C.), UL1TR001417, and UL1TR001079 and by Cystic Fibrosis Foundation grants CUTTIN13A1 and CUTTIN13A2. The Genetic Epidemiology of COPD (COPDGene) study is funded by the National Heart, Lung, and Blood Institute (grants R01 HL089897 and R01 HL089856) and by the COPD Foundation through contributions made to an industry advisory board comprised of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Siemens, and Sunovion. Funding Information: Supported by Agency for Healthcare Research and Quality grants R01-HS020642 and R24-HS022134.",

year = "2019",

month = jan,

doi = "10.1513/AnnalsATS.201805-325RL",

language = "English (US)",

volume = "16",

pages = "150--153",

journal = "Annals of the American Thoracic Society",

issn = "2325-6621",

publisher = "American Thoracic Society",

number = "1",

}

TY - JOUR

T1 - Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers

T2 - A cross-sectional study

AU - Teerapuncharoen, Krittika

AU - Michael Wells, J.

AU - Vamsee Raju, S.

AU - Raraigh, Karen S.

AU - Aksit, Melis Atalar

AU - Cutting, Garry R.

AU - Rasmussen, Lawrence

AU - Hrudaya Nath, P.

AU - Bhatt, Surya P.

AU - Solomon, George M.

AU - Dransfield, Mark T.

AU - Rowe, Steven M.

N1 - Funding Information: Supported by National Institutes of Health grants K08 HL123940 (J.M.W.), R01 HL105487 (S.M.R.), P30 DK072482 (S.M.R.), R01 DK44003 (G.R.C.), UL1TR001417, and UL1TR001079 and by Cystic Fibrosis Foundation grants CUTTIN13A1 and CUTTIN13A2. The Genetic Epidemiology of COPD (COPDGene) study is funded by the National Heart, Lung, and Blood Institute (grants R01 HL089897 and R01 HL089856) and by the COPD Foundation through contributions made to an industry advisory board comprised of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Siemens, and Sunovion. Funding Information: Supported by Agency for Healthcare Research and Quality grants R01-HS020642 and R24-HS022134.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85059240856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059240856&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201805-325RL

DO - 10.1513/AnnalsATS.201805-325RL

M3 - Letter

C2 - 30230364

AN - SCOPUS:85059240856

SN - 2325-6621

VL - 16

SP - 150

EP - 153

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

IS - 1

ER -

Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this